Immunocore Holdings IMCR
NASDAQ IMCR
$29.71 -0.83 (-2.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Cash & Current Investments (2019 - 2026)

Updated

Immunocore Holdings (IMCR) reported Cash & Current Investments of $880.22 million for Q2 2026, down 0.3% from $882.83 million a year earlier but up 4.2% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Immunocore Holdings posted Cash & Current Investments of $864.15 million, up 5.3% from FY2024.

  • Cash & Current Investments has increased for six consecutive years, with a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $820.38 million in FY2024 (+85.3%), $442.63 million in FY2023 (+13.5%), $390.04 million in FY2022 (+19.2%) and $327.3 million in FY2021 (+91.1%).
  • Five-year quarterly Cash & Current Investments spans a low of $262.02 million in Q2 2022 and a high of $901.28 million in Q3 2024.
  • Year over year, Cash & Current Investments gained in five of the last seven quarters, with growth averaging 13.4%.
  • The high point for year-over-year Cash & Current Investments in five years was Q2 2024 (growth of 100.7%); the low point was Q3 2025 (a decline of 1.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $844.9 million (Q1 2026), $864.15 million (Q4 2025) and $892.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Immunocore Holdings 1.53 Bn -1.95 Bn 114.84 Mn 880.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 880.22 Mn
Mar 31, 2026 844.90 Mn
Dec 31, 2025 864.15 Mn
Sep 30, 2025 892.35 Mn
Jun 30, 2025 882.83 Mn
Mar 31, 2025 837.05 Mn
Dec 31, 2024 820.38 Mn
Sep 30, 2024 901.28 Mn
Jun 30, 2024 859.60 Mn
Mar 31, 2024 832.82 Mn
Dec 31, 2023 442.63 Mn
Jun 30, 2023 428.39 Mn
Dec 31, 2022 390.04 Mn
Sep 30, 2022 409.18 Mn
Jun 30, 2022 262.02 Mn
Dec 31, 2021 320.67 Mn
Sep 30, 2021 353.68 Mn
Dec 31, 2020 171.28 Mn
Dec 31, 2019 95.10 Mn
API Access

Immunocore Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMCR&period=max&api_key=YOUR_API_KEY